|
|||||||||||||||||||||||||||||||||||||
 |
|||||||||||||||||||||||||||||||||||||
Press Releases See our recent press releases.
Features/Perspectives Hear and see company leadership, industry experts and patients discuss key issues and share their stories.
Media Contacts Find out who to contact if you are a member of the media.
Fact Sheets and Information Resources See additional resources for the media such as fact sheets, press kits and other information.
Corporate Overview Read a brochure about our company.
Positions / Policies Read our positions on various topics.
Baxter in the News Read recent news coverage and learn about events and recognition.
Sustainability Read our Sustainability Report and the latest news about our initiatives.
Investor Relations Read our annual report, proxy statements and other financial information.
Press Releases
Baxter Declares Quarterly Dividend
DEERFIELD, Ill., July 29, 2008 – The Board of Directors of Baxter International Inc. (NYSE:BAX) today declared a quarterly dividend of $0.2175 per share of Baxter common stock.
This payment represents a continuation of the current rate, which was increased earlier this year by 30 percent. This quarterly dividend is payable on October 1, 2008 to shareholders of record as of September 10, 2008.
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
| For More Information | |
| Media Contact: Deborah Spak 847-948-2349 |
Investoor Contacts: Mary Kay Ladone (847) 948-3371 Clare Trachtman (847) 948-3085 |
